Zydus Cadila: Only Needle-Free COVID Vaccine Gets Emergency Use Approval
Vaccine maker Zydus Cadila's needle-free three-dose Covid-19 vaccine finally got approval for emergency use in India by the Indian drug regulator's subject committee expert. The Ahmedabad-based company had applied for the approval of its vaccine ZyCoV-D, on July 1. Reportedly, the vaccine can be given to adults and children above 12 years of age for the first time in India. Zydus is planning on making over 100 million doses yearly.
Tags: Zydus Cadila, Covid Vaccination, DGCI, Indian drug manufacturer
Courtesy: NDTV
Indian Drugmaker Fined $50 Mn By US Govt For Irregularities
The US’ Department of Justice has fined an Indian drugmaker with $50 million for supplying low-grade active pharmaceutical ingredients used in cancer drugs distributed in the US. Reportedly, the Fresenius Kabi Oncology Limited (FKOL) had violated the Food and Drug Administration’s guidelines, concealed and spoiled records with FDA investigators. Moreover, the FDA said Active Pharmaceutical Ingredients produced at FKOL’s Bengal-based plant "… read-more
Tags: Indian drug manufacturer, FKOL, FDA, active pharmaceutical ingredients
Courtesy: The Indian Express